MorphoSys AG
Utility Patent Applications
Last updated:
List of all MorphoSys AG patents 35 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS Filling date: 8 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: ANTI-CD19 THERAPY IN PATIENTS HAVING A LIMITED NUMBER OF NK CELLS Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: ANTI-CD19 ANTIBODY FORMULATIONS Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ANTI-CD38 ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF AUTOANTIBODY-MEDIATED AUTOIMMUNE DISEASE Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 Region Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: ANTIBODIES TARGETING C5AR Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: ANTIBODY FORMULATIONS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: PHARMACEUTICAL COMBINATIONS FOR TREATING TUMOR COMPRISING ANTI-CD19 ANTIBODY AND NATURAL KILLER CELL Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULES Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: ANTI-GM-CSF ANTIBODIES Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: CANINE ANTIBODY LIBRARIES Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 Filling date: 8 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT Filling date: 8 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: High Concentration Liquid Antibody Formulations Filling date: 8 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTIBODIES TARGETING GLYCOPROTEIN VI Filling date: 8 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: TREATMENT FOR RHEUMATOID ARTHRITIS Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR LYMPHOMA Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: PEPTIDE LIBRARIES Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: HUMANIZED ANTIBODIES FOR CD3 Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: POLYPEPTIDE LIBRARY Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: CANINE ANTIBODY LIBRARIES Filling date: 8 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: ANTIBODIES FOR IL-17C Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: TREATMENT FOR MULTIPLE MYELOMA (MM) Filling date: 8 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTI-GM-CSF ANTIBODIES Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ANTIBODIES FOR IL-17C Filling date: 8 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: FAB MOLECULES WITH A RODENT HINGE REGION AND A NON-RODENT CH1 REGION Filling date: 8 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: ANTI-CD19 ANTIBODY FORMULATIONS Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: POLYPEPTIDE LIBRARY Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Showing 1 to 35 of 35 patents.